MedPlus Health Services Ltd
NSE:MEDPLUS
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| IN |
|
MedPlus Health Services Ltd
NSE:MEDPLUS
|
99.5B INR |
Loading...
|
|
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
78.3B ZAR |
Loading...
|
|
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31.3B ZAR |
Loading...
|
|
| JP |
|
Sapporo Clinical Laboratory Inc
TSE:9776
|
3.1T JPY |
Loading...
|
|
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD |
Loading...
|
|
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
45.3B BRL |
Loading...
|
|
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
1.3T JPY |
Loading...
|
|
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
1T JPY |
Loading...
|
|
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR |
Loading...
|
|
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY |
Loading...
|
|
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
29.6B CNY |
Loading...
|
Market Distribution
| Min | -3 052.3% |
| 30th Percentile | 26.9% |
| Median | 39% |
| 70th Percentile | 53.3% |
| Max | 8 269.1% |
Other Profitability Ratios
MedPlus Health Services Ltd
Glance View
MedPlus Health Services Ltd., once a nascent venture in India's vast healthcare landscape, has emerged as a formidable player in retail pharmacy, reflecting a trajectory marked by strategic growth and innovation. Founded in 2006 by Dr. Madhukar Gangadi, the company set out with a vision to bridge the gap in quality and accessibility within the pharmaceutical domain. MedPlus capitalized on a straightforward yet powerful business model - creating a wide-reaching network of stores that combine the traditional trust of a neighborhood pharmacy with a technology-driven supply chain. This approach not only ensured the availability of a vast range of pharmaceuticals and health products but also made these essentials more accessible to consumers via competitive pricing. Its brick-and-mortar outlets, coupled with an expansive online platform, enable MedPlus to seamlessly serve a diverse clientele across urban and semi-urban areas. Financially, MedPlus generates revenue primarily through the sale of prescription and over-the-counter medicines, supplements, personal care, and home healthcare products. The company's prowess lies in its hybrid model, utilizing physical stores as local fulfillment centers for its robust e-commerce business, which promises convenience and swift deliveries. By integrating an expansive logistics network and investing in IT infrastructure, MedPlus ensures operational efficiency that reduces lead times and maintains customer satisfaction. Furthermore, its loyalty programs and customer-centric services foster brand allegiance, driving repeat business. This blend of traditional retail strengths with the scalability of digital channels positions MedPlus not just as a retail pharmacy chain, but as a comprehensive health solutions provider, adept at navigating the evolving demands of the healthcare industry.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for MedPlus Health Services Ltd is 26.2%, which is above its 3-year median of 23.3%.
Over the last 3 years, MedPlus Health Services Ltd’s Gross Margin has increased from 21.6% to 26.2%. During this period, it reached a low of 21.6% on Dec 31, 2022 and a high of 26.2% on Jan 1, 2026.